Publication | Closed Access
Adjuvant gemcitabine-docetaxel chemotherapy for stage I uterine leiomyosarcoma: Trends and survival outcomes
51
Citations
25
References
2017
Year
Survival OutcomesMedicineMetronomic TherapyGynecologyCancer TreatmentOncologyRadiation OncologyGynecology OncologyAdjuvant Gemcitabine-docetaxel Chemotherapy
| Year | Citations | |
|---|---|---|
Page 1
Page 1